EN
Enzolytics Inc.
ENZC · OTC
$0.00 +66.67% (+$0.00)
1M -16.67%
Market Cap $2.76M
P/E Ratio -
Div. Yield -
ROE 0.33%
Piotroski F-Score Weak
2/9Valuation
-
N/A P/E N/A
EV/FFO N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
1 /100
Poor ROIC 0.31%
Asset turnover 0.00x
ROE 0.33%
Debt
53 /100
Moderate Current ratio 0.63x
Net debt/EBITDA -2.97x
Int. coverage -9.69x
Stability
29 /100
Unstable Beta 0.51x
Profitable years 0
EPS volatility 256.46%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ENZC
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Steven Sharabura
Employees
1
Headquarters
Plano